Biotechnologies - into life

Found results: 262

Biotechnologies - into life

Artificial organs: Russian gasoline, Italian ideas

On the basis of the Kuban Medical University, Italian surgeon Paolo Macchiarini is deploying a laboratory of regenerative medicine. It is assumed that in two years in Krasnodar they will learn how to grow human organs.

23.01.2012
Biotechnologies - into life

Russian-British-German Biopharmaceuticals

For the first time, a Russian company initiates the creation of a new powerful player in the global market of innovative pharmaceuticals.

01.12.2011
Biotechnologies - into life

Biohackers, welcome!

The first biohacker farm, consisting of a laboratory, an office and a coworking area, mandatory for a collective startup, for collaboration and exchange of ideas, will open its doors next week.

20.10.2011
Biotechnologies - into life

Biopharmaceuticals at the forefront of knowledge

At the IV All-Russian Science Festival, the organizers of the competition of scientific papers in the field of chemistry, biology and pharmacy "Vanguard of Knowledge" awarded the authors of the best scientific papers in the field of cardiology and oncology.

10.10.2011
Biotechnologies - into life

Ideon: a success story

The foundation of the first building of the technopark in the Swedish city of Lund was laid in September 1983, and a few months later the first two start-up pharmaceutical companies became its residents. Today, the results of Ideon impress even skeptics.

20.09.2011
Biotechnologies - into life

Hypersensitive microparticles for cancer diagnosis

Microparticles from hydrogel make it possible to determine the miRNA profiles characteristic of various types of cancer and other diseases in blood samples. The new method is 100 times more sensitive and much more accurate than the existing ones.

01.09.2011
Biotechnologies - into life

Biomedicine in Skolkovo: new residents

The Skolkovo biomedical cluster includes a number of companies planning to develop and launch innovative diagnostic systems and biopharmaceuticals on the Russian market.

27.05.2011
Biotechnologies - into life

Membrane protein research has found an investor

MIPT and the private investment fund ONEXIM announced the launch of a joint project to create a laboratory "Advanced research of membrane Proteins" on the basis of the interdisciplinary Scientific and Educational Center "Bionanophysics".

27.05.2011
Biotechnologies - into life

Goat Lactoferrin: Slow hurdling

Despite all the financial difficulties and legal difficulties, the implementation of the Russian lactoferrin project is not a hopeless thing.

13.04.2011
Biotechnologies - into life

About biopolymers, biotechnologies and drug production

Yuri Vorobyov, Chief Researcher at the Institute of Chemical Biology and Fundamental Medicine of the SB RAS, spoke about research that will improve biotechnology and the process of drug production and about the work of a scientist in Russia and the USA.

25.03.2011
Biotechnologies - into life

Biomedicine in Skolkovo: details

The strategic goal of the Skolkovo biomedical cluster is to create an infrastructure ecosystem for innovations in the field of biomedical technologies.

10.03.2011
Biotechnologies - into life

Skulachev ions protect the kidneys

A mitochondrial antioxidant based on the SkQR1 molecule from the class of "Skulachev ions" protects the kidneys from oxidative stress that develops with various lesions of internal organs.

11.02.2011
Biotechnologies - into life

Scandinavian Skolkovo

The Danish-Swedish Medicon Valley is one of the largest clusters in Europe, where research laboratories, commercial structures and industrial enterprises related to the vast industry called life—sciences - "life sciences" are concentrated.

11.02.2011
Biotechnologies - into life

Cancer treatment: from early diagnosis to gene therapy and preventive vaccine

Sergey Larin, Head of the Laboratory of Gene Therapy of the IBG RAS, spoke about the results and future of the project "Development of technologies for genodiagnostics and gene therapy of cancer and production of prototypes of test kits and gene-cell antitumor vaccines".

31.01.2011
Biotechnologies - into life

HimRar: the success story is not over

Interview with Andrey Ivashchenko, Chairman of the Board of Directors of the HimRar Group of Companies, about the main trends in the global pharmaceutical industry, how to preserve scientific potential and convert it into a successful business, and what problems stand in this way.

25.01.2011